Editorial Policies


Authorship credit should be based only on (1) substantial contributions to the conception or design of the work, or acquisition, analysis or interpretation of data for the work; (2) drafting the work or revising it critically for important intellectual content; (3) final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors and their contributions must be mentioned in the “Author Contribution Statement”.

Acquisition of funding, the collection of data, or general supervision of the research group do not, by themselves, justify authorship, nor does the fact of being in sole charge of the clinic or organisational unit in which the article was prepared. Such contributions should be listed as Acknowledgements, as well as those of colleagues who provided reagents, discussions and critical input, editorial help, technical services, etc.


Disclosure of Financial and Non-Financial Relationships and Activities, and Conflicts of Interest

Any financial or personal connections that exist in connection with the submitted work must be indicated in the author form and in the «Conflicts of Interest» section of the manuscript. The corresponding form must be signed by all authors and submitted.

Conflict of Interest Form 


Duplicate Submissions

Submission of a paper to «Cardiovascular Medicine» is understood to imply that the data contained therein has not previously been published (except in abstract form) or is being considered for publication elsewhere.

All submissions to Cardiovascular Medicine should conform to the «Uniform Requirements for Manuscripts Submitted to Biomedical Journals».

Previously published data can be reproduced in exceptional cases, provided that a full disclosure is made and a plausible reason for republication is given. 


Plagiarism Detection / Scientific misconduct

EMH Swiss Medical Publishers Ltd. is a member of CrossCheck, a service offered by CrossRef and powered by iThenticate software. In our online editorial system, all newly submitted manuscripts are automatically compared with the CrossCheck database. Submissions with overlaps to already published articles are carefully checked for plagiarism by the editorial team. 

Scientific misconduct includes but is not necessarily limited to data fabrication, data falsification, purposeful failure to disclose relationships and activities, and plagiarism. We take allegations of misconduct very seriously. Problems concerning scientific misconduct are dealt following the guidelines of the «Committee on Publication Ethics» (COPE), the «World Association of Medical Editors» (WAME) and the «International Committee of Medical Journal Editors» (ICMJE). 


Obligation to Register Clinical Trials 

We require registration of interventional trials in a primary register that participates in WHO's «International Clinical Trial Registry» or in ClinicalTrials.gov at or before the time of first patient enrollment as a condition of consideration for publication, in accord with ICMJE recommendations


Ethics Approval of Research

We require every article reporting results of prospective research using human subjects or samples, or results of animal research, to include a statement that the study obtained ethical approval, including the name of the ethics committee(s) or institutional review board(s) and the number/ID of the approval(s). Where ethical approval is not required, the manuscript should include a clear statement of this and the reason why.

When reporting research involving human data, authors should indicate whether the procedures followed were assessed and approved by a legally qualified ethics review committee (institutional or national) or, if no formal ethics committee is available, were in accordance with the Helsinki Declaration as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the study. Approval by a responsible review committee does not preclude editors from forming their own judgement whether the conduct of the research was appropriate.

When reporting experiments on animals, authors should indicate whether the institutional and national guides for the care and use of laboratory animals were followed.


Protection of Patients’ Rights to Privacy 

Patients have a right to privacy that should not be infringed without informed consent.

Information that allows conclusions to be drawn about the identity will only be published if it is indispensable for the scientific content of the communication and written consent has been obtained from the person concerned («informed consent»; also in the case of illustrations). This consent must be archived by the authors. A confirmation of the existence of the «Informed Consent» signed by the patient must be sent to the publisher. 

Informed Consent Form

The persons concerned must be informed that the article will also be accessible open access on the Internet. 


Data Availability

Manuscripts reporting clinical trial results must include a Data Availability Statement.


Review Process

There are no «Article Processing Charges" (APCs) or «Page Charges"associated with this journal.

Prior to publication, all manuscripts, with the exception of Editorials and Letters to the Editors, undergo a single blind peer review, conducted by independent experts in the field.

The language of original articles is English. Other contributions should preferably be in English, otherwise they can be in German or French.
The Editorial Board may decline a paper on the basis of internal review. Authors who believe that their article has been rejected unfairly may submit an appeal via our online submission system or by sending an e-mail to the editorial office.

Editors and reviewers are explicitly requested to report conflicts of interest that could influence their opinion of the manuscript in question, in which case they will be excluded from the reviewing process of this manuscript. When an editor is author or co-author of a manuscript, she or he is excluded from publication decisions and has no insight into the reviewing process of the article in the manuscript management system.


Post-Publication Discussions 

We welcome debate post publication either through letters to the editor or the comment function at the bottom of every article.

If a correction of a published article is needed it is dealt with following the ICMJE guidelines